$144.15 B
Share price
Change (1 day)
Change (1 year)

The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.

Market capitalization of Amgen (AMGN)

Market cap: $144.15 Billion

As of December 2023 Amgen has a market cap of $144.15 Billion. This makes Amgen the world's 82th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Amgen from 2001 to 2023

End of year Market Cap

Year Market cap Change
2023$144.15 B2.86%
2022$140.13 B10.59%
2021$126.71 B-5.33%
2020$133.85 B-6.11%
2019$142.56 B16.32%
2018$122.56 B-2.91%
2017$126.23 B16.06%
2016$108.76 B-11.13%
2015$122.39 B1.05%
2014$121.12 B40.7%
2013$86.08 B32.05%
2012$65.19 B15.83%
2011$56.28 B10%
2010$51.16 B-9.1%
2009$56.28 B-6.91%
2008$60.46 B19.78%
2007$50.48 B-36.62%
2006$79.64 B-17.48%
2005$96.52 B19.42%
2004$80.82 B1.9%
2003$79.31 B27.29%
2002$62.31 B5.57%
2001$59.02 B

End of Day market cap according to different sources

On Dec 6th, 2023 the market cap of Amgen was reported to be:

$144.15 Billion
by Yahoo Finance info icon info icon
$144.15 Billion
by CompaniesMarketCap info icon info icon
$144.18 Billion
by Iex Cloud info icon info icon
$144.15 Billion
by Nasdaq info icon info icon
$144.96 Billion
by Reuters info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$377.02 B 161.55%๐Ÿ‡บ๐Ÿ‡ธ USA
$162.56 B 12.77%๐Ÿ‡บ๐Ÿ‡ธ USA
$258.43 B 79.29%๐Ÿ‡บ๐Ÿ‡ธ USA
$559.37 B 288.05%๐Ÿ‡บ๐Ÿ‡ธ USA
$33.88 B-76.49%๐Ÿ‡บ๐Ÿ‡ธ USA
$98.88 B-31.40%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.10 B-87.44%๐Ÿ‡บ๐Ÿ‡ธ USA
$101.49 B-29.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$75.20 B-47.83%๐Ÿ‡ฌ๐Ÿ‡ง UK